Bond Sumitomo Mitsui FG Inc. 2.142% ( US86562MBZ23 ) in USD

Sumitomo Mitsui FG Inc.

86.057 % ▲

Japan

US86562MBZ23 ( in USD )

2.142% per year ( payment 2 times a year)

22/09/2030

Prospectus brochure of the bond Sumitomo Mitsui Financial Group Inc US86562MBZ23 en USD 2.142%, maturity 22/09/2030

2 000 USD

850 000 000 USD

86562MBZ2

BBB+ ( Lower medium grade - Investment-grade )

A2 ( Upper medium grade - Investment-grade )

23/09/2025 ( In 140 days )

Sumitomo Mitsui Financial Group, Inc. (SMFG) is a major Japanese financial services holding company offering a wide range of banking, securities, and insurance services both domestically and internationally.

The Bond issued by Sumitomo Mitsui FG Inc. ( Japan ) , in USD, with the ISIN code US86562MBZ23, pays a coupon of 2.142% per year.
The coupons are paid 2 times per year and the Bond maturity is 22/09/2030

The Bond issued by Sumitomo Mitsui FG Inc. ( Japan ) , in USD, with the ISIN code US86562MBZ23, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency.

The Bond issued by Sumitomo Mitsui FG Inc. ( Japan ) , in USD, with the ISIN code US86562MBZ23, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency.

PROSPECTUS SUPPLEMENT
(To prospectus dated December 20, 2018)
Sumitomo Mitsui Financial Group, Inc.
(incorporated under the laws of Japan with limited liability)
U.S.$850,000,000 2.142% Subordinated Notes due 2030
We will issue an aggregate principal amount of $850,000,000 of subordinated notes due September 23, 2030, or the notes. The notes will
bear interest commencing September 23, 2020 at the rate of 2.142% per annum, payable semiannually in arrears on March 23 and September
23 of each year, beginning on March 23, 2021.
We may, at our option, redeem the notes in whole, but not in part, upon the occurrence of certain changes in Japanese tax law or certain
changes in Japanese regulatory capital requirements, as described under "Description of the Notes--Redemption for Taxation Reasons" and
"Description of the Notes--Redemption for Regulatory Reasons," respectively. The notes will be our direct and unsecured obligations and
will at all times rank pari passu and without any preference among themselves and at least equally and ratably with all of our indebtedness
that is subordinated to our senior indebtedness and is in priority to all of our perpetual subordinated indebtedness, as described herein.
The notes contain non-viability loss absorption provisions, pursuant to which, if a Non-Viability Event (as defined herein) occurs, the full
principal amount of the notes will be permanently written down to zero, the notes will be cancelled and the holders of the notes will be deemed
to have irrevocably waived their right to claim or receive any payment of principal of or interest on the notes (including additional amounts with
respect thereto, if any), except for any payments of principal or interest (including additional amounts with respect thereto, if any) that have
become due and payable prior to the occurrence of the Non-Viability Event, as described further herein under "Description of the Notes--Write-
Down upon a Non-Viability Event."
Unless previously redeemed or otherwise cancelled, and provided that a Non-Viability Event has not occurred, the notes will mature on
September 23, 2030. The notes will be issued only in registered form in denominations of $2,000 and integral multiples of $1,000 in excess
thereof and will not be subject to a sinking fund.
We have made an application to the Luxembourg Stock Exchange to list the notes on the official list of the Luxembourg Stock Exchange
and for such notes to be admitted to trading on the Luxembourg Stock Exchange's Euro MTF Market. The Luxembourg Stock Exchange's
Euro MTF Market is not a regulated market for the purposes of Directive 2014/65/EU. This prospectus supplement constitutes a prospectus
for purposes of Part IV of the Luxembourg law on prospectus securities dated July 16, 2019.
This prospectus supplement does not constitute a prospectus for the purposes of Regulation (EU) 2017/1129.
Investing in the notes involves risks. You should carefully consider the risk factors set forth in "Item 3. Key Information--Risk
Factors" of our most recent annual report on Form 20-F filed with the U.S. Securities and Exchange Commission, or the SEC, and in
the "Risk Factors" section beginning on page S-10 of this prospectus supplement before making any decision to invest in the notes.
Per note
Total
Public offering price(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100%
U.S.$850,000,000
Underwriting commissions(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
0.45%
U.S.$
3,825,000
Proceeds, before expenses, to SMFG(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
99.55%
U.S.$846,175,000
(1) Plus accrued interest from September 23, 2020, if settlement occurs after that date.
(2) For additional underwriting compensation information, see "Underwriting (Conflicts of Interest)."
Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus supplement or the related prospectus. Any representation to the contrary is a criminal
offense.
The notes will be represented by one or more global certificates deposited with a custodian for, and registered in the name of a nominee
of, The Depository Trust Company, or DTC. Beneficial interests in these global certificates will be shown on, and transfers thereof will be
effected through, records maintained by DTC and its direct and indirect participants, including Euroclear Bank SA/NV, or Euroclear, and
Clearstream Banking S.A., or Clearstream. Except as described in this prospectus supplement or the accompanying prospectus, notes in
definitive certificated form will not be issued in exchange for global certificates.
It is expected that the notes will be delivered in book-entry form only, through the facilities of DTC and its participants, including
Euroclear and Clearstream, on or about September 23, 2020.
Joint Lead Managers and Joint Bookrunners
SMBC NIKKO
Goldman Sachs & Co. LLC
BofA Securities
Citigroup
Senior Co-Manager
BNP PARIBAS
Co-Managers
Daiwa Capital Markets
J.P. Morgan
Nomura
Barclays
UBS Investment Bank
Prospectus Supplement dated September 14, 2020

TABLE OF CONTENTS
Prospectus Supplement
Page
Prospectus Supplement Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-1
Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-10
Use of Proceeds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-18
Capitalization and Indebtedness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-19
Selected Financial and Other Information (IFRS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-20
Supplemental Financial and Other Information (Japanese GAAP) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-22
Description of the Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-29
Taxation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-37
Benefit Plan Investor Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-47
Underwriting (Conflicts of Interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-49
Listing and General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-55
Legal Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-56
Incorporation By Reference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S-57
Prospectus
Page
About This Prospectus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1
Cautionary Statement Regarding Forward-Looking Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2
Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3
Sumitomo Mitsui Financial Group, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3
Capitalization and Indebtedness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4
Use of Proceeds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5
Description of the Debt Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6
Taxation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22
Benefit Plan Investor Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22
Plan of Distribution (Conflicts of Interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24
Market-Making Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
25
Experts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27
Legal Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27
Enforcement of Civil Liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27
Where You Can Find More Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27
S-ii

The notes have not been and will not be registered under the Financial Instruments and Exchange Act of
Japan, or the FIEA, and are subject to the Act on Special Measures Concerning Taxation of Japan, or the Special
Taxation Measures Act. The notes may not be offered or sold in Japan, to any person resident in Japan, or to
others for reoffering or resale directly or indirectly in Japan or to a person resident in Japan, for Japanese
securities law purposes (including any corporation or other entity organized under the laws of Japan) except
pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the FIEA and
any other applicable laws, regulations and governmental guidelines of Japan. In addition, the notes are not, as
part of the distribution by the underwriters under the applicable underwriting agreement at any time, to be
directly or indirectly offered or sold to, or for the benefit of, any person other than a beneficial owner that is,
(i) for Japanese tax purposes, neither an individual resident of Japan or a Japanese corporation, nor an individual
non-resident of Japan or a non-Japanese corporation that in either case is a person having a special relationship
with the issuer of the notes as described in Article 6, Paragraph (4) of the Special Taxation Measures Act, or a
specially-related person of the issuer or (ii) a Japanese financial institution, designated in Article 6, Paragraph
(9) of the Special Taxation Measures Act, except as specifically permitted under the Special Taxation Measures
Act.
Interest payments on the notes will be subject to Japanese withholding tax unless it is established that the
notes are held by or for the account of a beneficial owner that is (i) for Japanese tax purposes, neither an
individual resident of Japan or a Japanese corporation, nor an individual non-resident of Japan or a non-Japanese
corporation that in either case is a specially-related person of the issuer, (ii) a Japanese financial institution
designated in Article 6, Paragraph (9) of the Special Taxation Measures Act which complies with the requirement
for tax exemption under that paragraph or (iii) a Japanese public corporation, financial institution or financial
instruments business operator described in Article 3-3, Paragraph (6) of the Special Taxation Measures Act
which complies with the requirement for tax exemption under that paragraph.
Interest payments on the notes to an individual resident of Japan, to a Japanese corporation (except as
described in the preceding paragraph), or to an individual non-resident of Japan or a non-Japanese corporation
that in either case is a specially-related person of the issuer will be subject to deduction in respect of Japanese
income tax at a rate of 15.315% (15% on or after January 1, 2038) of the amount of such interest.
Representation by Investor upon Distribution
By subscribing to any notes, an investor will be deemed to have represented that it is a beneficial owner who
is, (i) for Japanese tax purposes, neither an individual resident of Japan or a Japanese corporation, nor an
individual non-resident of Japan or a non-Japanese corporation that in either case is a person having a special
relationship with the issuer of the notes as described in Article 6, Paragraph (4) of the Special Taxation Measures
Act or (ii) a Japanese financial institution, designated in Article 6, Paragraph (9) of the Special Taxation
Measures Act.
PROHIBITION OF SALES TO EEA AND U.K. RETAIL INVESTORS--The notes are not intended to
be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to
any retail investor in the European Economic Area, or the EEA, or in the United Kingdom, or the U.K. For these
purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of
Article 4(1) of Directive 2014/65/EU, as amended, or MiFID II; or (ii) a customer within the meaning of
Directive (EU) 2016/97, or the Insurance Distribution Directive, where that customer would not qualify as a
professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined
in Regulation (EU) 2017/1129, as amended, or the Prospectus Regulation. Consequently no key information
document required by Regulation (EU) No 1286/2014, as amended, or the PRIIPs Regulation, for offering or
selling the notes or otherwise making them available to retail investors in the EEA or in the U.K. has been
prepared and therefore offering or selling the notes or otherwise making them available to any retail investor in
the EEA or in the U.K. may be unlawful under the PRIIPs Regulation.
S-iii

NOTIFICATION UNDER SECTION 309B OF THE SFA--In connection with Section 309B of the
Securities and Futures Act (Chapter 289) of Singapore, or the SFA, and the Securities and Futures (Capital
Markets Products) Regulations 2018 of Singapore, or the CMP Regulations 2018, we have determined, and
hereby notify all relevant persons (as defined in Section 309(A)(1) of the SFA), that the notes are "prescribed
capital markets products" (as defined in the CMP Regulations 2018) and Excluded Investment Products (as
defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16:
Notice on Recommendations on Investment Products).
ABOUT THIS PROSPECTUS SUPPLEMENT
This document consists of two parts. The first part is this prospectus supplement, which describes the
specific terms of the offering of the notes and also adds to, updates and changes information contained in the
prospectus dated December 20, 2018 and filed with the SEC on the same date, and the documents incorporated
by reference in this prospectus supplement. The second part is the above-mentioned prospectus, to which we
refer as the "accompanying prospectus." The accompanying prospectus contains a description of the senior and
subordinated debt securities and gives more general information, some of which may not apply to the notes. If
the description of the notes in this prospectus supplement differs from the description in the accompanying
prospectus, the description in this prospectus supplement supersedes the description in the accompanying
prospectus.
We have not, and the underwriters have not, authorized any other person to provide you with any
information other than that contained in or incorporated by reference into this prospectus supplement, in the
accompanying prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have
referred you. "Incorporated by reference" means that we can disclose important information to you by referring
you to another document filed separately with the SEC. We are not responsible for, and can provide no assurance
as to the accuracy of, any other information that any other person may give you. We are not making, nor are the
underwriters making, an offer to sell the notes in any jurisdiction where the offer or sale is not permitted. You
should not assume that the information appearing in this prospectus supplement, the accompanying prospectus or
in any free writing prospectus prepared by or on behalf of us or to which we have referred you, including any
information incorporated by reference herein or therein, is accurate as of any date other than its respective date.
Our business, financial condition, results of operations and prospects may have changed since those respective
dates.
Copies of the documents incorporated by reference in this prospectus supplement as of the date of this
prospectus supplement will be available free of charge at the offices of the trustee and on the website of the
Luxembourg Stock Exchange (www.bourse.lu). This prospectus supplement may only be used for the purposes
for which it has been published.
FORWARD-LOOKING STATEMENTS
This prospectus supplement, the accompanying prospectus and the documents incorporated by reference
herein contain in a number of places forward-looking statements regarding our intent, belief or current
expectations of our management with respect to the future results of operations and financial condition of us,
SMBC and our respective group companies, including without limitation future loan loss provisions and financial
support to borrowers. In many cases but not all, the words "anticipate," "believe," "estimate," "expect," "intend,"
"may," "plan," "probability," "project," "risk," "seek," "should," "target," "will" and similar expressions, as they
relate to us or our management, are intended to identify forward-looking statements. You can also identify
forward-looking statements by discussions of strategy, plans or intentions. Forward-looking statements, which
include statements contained in "Item 3. Key Information--Risk Factors," "Item 5. Operating and Financial
Review and Prospects" and "Item 11. Quantitative and Qualitative Disclosures about Credit, Market and Other
S-iv

Risk" of our annual report on Form 20-F for the fiscal year ended March 31, 2020, reflect our current views with
respect to future events and are subject to risks, uncertainties and assumptions, including the risk factors
described in this prospectus supplement. Should one or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual results may vary materially from those described here as
anticipated, believed, estimated, expected or intended.
We have identified some of the risks inherent in forward-looking statements in "Item 3. Key Information--
Risk Factors" of our most recent annual report on Form 20-F and in the "Risk Factors" section of this prospectus
supplement. Other factors could also adversely affect our results or the accuracy of forward-looking statements in
this prospectus supplement, and you should not consider these to be a complete set of all potential risks or
uncertainties.
The forward-looking statements included or incorporated by reference in this prospectus supplement are
made only as of the dates on which such statements were made. We expressly disclaim any obligation or
undertaking to release any update or revision to any forward-looking statement contained herein to reflect any
change in our expectations with regard thereto or any change in events, conditions or circumstances on which
any statement is based.
PRESENTATION OF FINANCIAL AND OTHER INFORMATION
Our primary financial statements for SEC reporting purposes are prepared on an annual and semi-annual
basis in accordance with International Financial Reporting Standards as issued by the International Accounting
Standards Board, or IFRS, while our financial statements for reporting in our jurisdiction of incorporation and
Japanese bank regulatory purposes are prepared on an annual and quarterly basis in accordance with accounting
principles generally accepted in Japan, or Japanese GAAP.
Financial information for us contained or incorporated by reference herein is presented in accordance with
IFRS or Japanese GAAP, as specified herein or in the relevant document being incorporated by reference.
Financial information for SMBC contained or incorporated by reference herein is presented in accordance with
Japanese GAAP. See "Incorporation by Reference" for a list of documents being incorporated by reference
herein.
IFRS and Japanese GAAP differ in certain respects from each other and from generally accepted accounting
principles in the United States, or U.S. GAAP, and in other countries. For a description of certain differences
between IFRS and Japanese GAAP, see "Item 5.A. Operating Results--Reconciliation with Japanese GAAP" in
our most recent annual report on Form 20-F filed with the SEC. You should consult your own professional
advisers for a more complete understanding of the differences between IFRS, Japanese GAAP, U.S. GAAP and
the generally accepted accounting principles of other countries and how those differences might affect the
financial information contained or incorporated by reference in this prospectus supplement or the accompanying
prospectus.
In this prospectus supplement, where IFRS financial information is presented in millions, billions or trillions
of yen or thousands, millions or billions of dollars, amounts of less than one thousand, one million, one billion or
one trillion, as the case may be, have been rounded. Where Japanese GAAP financial information is presented in
millions of yen or thousands or millions of dollars, amounts of less than one thousand or one million, as the case
may be, have been truncated. Where Japanese GAAP financial information is presented in billions or trillions of
yen or billions of dollars, amounts of less than one billion or one trillion, as the case may be, have been rounded,
except for information of SMBC Nikko Securities Inc., or SMBC Nikko Securities, the amounts of which have
been truncated. Accordingly, the total of each column of figures may not be equal to the total of the individual
items. All percentages have been rounded to the nearest percent, one-tenth of one percent or one-hundredth of
one percent, as the case may be, except for capital ratios, which have been truncated.
S-v

Unless otherwise specified or required by the context: references to "days" are to calendar days; references
to "years" are to calendar years and to "fiscal years" are to our fiscal years ending on March 31; references to
"$," "U.S.$," "dollars" and "U.S. dollars" are to United States dollars, references to "yen" and "¥" are to
Japanese yen and references to "" are to the euro, the currency of those member states of the European Union
that are participating in the European Economic and Monetary Union pursuant to the Treaty on European Union.
Unless otherwise specified, when converting currencies into yen we use Sumitomo Mitsui Banking Corporation's
median exchange rates for buying and selling spot dollars, or other currencies, by telegraphic transfer against yen
as determined at the end of the relevant fiscal period. Unless the context otherwise requires, "SMFG," the
"issuer," "we," "us," "our," and similar terms refer to Sumitomo Mitsui Financial Group, Inc. as well as to its
subsidiaries. "SMBC" refers to Sumitomo Mitsui Banking Corporation, which is one of our commercial banking
subsidiaries, or to Sumitomo Mitsui Banking Corporation and its subsidiaries, taken as a whole, as the context
requires. References to "non-consolidated" information are to the financial information solely of SMBC.
References to the "SMBC Group" are to us and our subsidiaries and affiliates taken as a whole.
In this prospectus supplement, all of our financial information is presented on a consolidated basis, unless
we state otherwise.
S-vi

PROSPECTUS SUPPLEMENT SUMMARY
This summary highlights key information described in greater detail elsewhere, or incorporated by
reference, in this prospectus supplement and the accompanying prospectus. You should read carefully the entire
prospectus supplement, the accompanying prospectus and the documents incorporated by reference before
making an investment decision.
Our Company
We are a joint stock company incorporated in December 2002 with limited liability under the laws of Japan.
We are a holding company that directly owns 100% of the issued and outstanding shares of SMBC, which is one
of the largest commercial banks in Japan and can trace the origin of its banking business back to the seventeenth
century. We are one of the three largest banking groups in Japan, with an established presence across all of the
consumer and corporate banking sectors. In addition to SMBC, we are a holding company for SMBC Trust Bank
Ltd., or SMBC Trust Bank, Sumitomo Mitsui Finance and Leasing Company, Limited, or SMFL, SMBC Nikko
Securities, Sumitomo Mitsui Card Company, Limited, or Sumitomo Mitsui Card, SMBC Consumer Finance Co.,
Ltd., or SMBC Consumer Finance, The Japan Research Institute, Limited, or The Japan Research Institute,
Sumitomo Mitsui DS Asset Management Company, Limited, or SMDAM, and other subsidiaries and affiliates.
Through our subsidiaries and affiliates, we offer a diverse range of financial services, including commercial
banking, leasing, securities, consumer finance and other services.
SMBC is one of the world's largest commercial banks on the basis of total assets and provides an extensive
range of corporate and consumer banking services in Japan and wholesale banking services overseas. In Japan, it
has solid franchises in both corporate and consumer banking. SMBC has long-standing and close business
relationships with many companies listed on the First Section of the Tokyo Stock Exchange and long historical
relationships with Sumitomo Group and Mitsui Group companies.
We continue promoting business collaborations among SMBC Group companies, including SMBC, SMBC
Trust Bank, SMFL, SMBC Nikko Securities, The Japan Research Institute and SMDAM in the corporate
solutions business and SMBC, SMBC Trust Bank, SMBC Nikko Securities, Sumitomo Mitsui Card, SMBC
Consumer Finance and SMDAM in providing financial consulting services to individuals.
Our registered head office is located at 1-2, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-0005, Japan. Our
main telephone number is +81-3-3282-8111, and our corporate website is https://www.smfg.co.jp. Information
appearing on our website is not incorporated by reference into this prospectus supplement.
Concurrent Senior Notes Offering
We regularly issue senior and subordinated debt securities in a variety of currencies and issuance formats.
On September 14, 2020, we announced our intention to issue additional 5-year senior notes as a further issuance
of the 1.474% senior notes due 2025 that we issued on July 8, 2020 (the "Concurrent Senior Notes"). We intend
to use the proceeds therefrom to extend unsecured loans, intended to qualify as internal TLAC, to SMBC. SMBC
intends to use the proceeds of the loans for general corporate purposes. The pricing of the offering and the
delivery of the Concurrent Senior Notes are expected to occur at a similar timing as the offering of the notes. No
Concurrent Senior Notes are being offered hereby. The closing of the offering of the Concurrent Senior Notes is
not conditional upon the closing of the offering of the notes, and vice versa.
S-1

Recent Developments and Outlook
We are closely monitoring developments related to the COVID-19 pandemic to assess its ongoing impact on
our business. Since the onset of the COVID-19 outbreak, our business has been subject to a variety of adverse
impacts, including to our financial results for the fiscal year ended March 31, 2020. For more information, refer
to "Item 3.D. Key Information--Risk Factors" and "Item 5. Operating and Financial Review and Prospects" in
our most recent annual report on Form 20-F filed with the SEC, which is incorporated by reference herein. Our
financial results continued to be negatively impacted by the COVID-19 pandemic for the three months ended
June 30, 2020. In particular, consolidated gross profit declined due to the negative impact of COVID-19 on fees
from credit card sales and wholesale non-interest income, partially offset by gains on sales of bonds driven by
lower global interest rates. An increase in credit costs in both domestic and overseas businesses due to the
COVID-19 pandemic contributed to a significant year-on-year decrease in profit attributable to owners of parent.
See "Supplemental Financial and Other Information (Japanese GAAP)."
We are also expecting the COVID-19 pandemic to have a substantial negative impact on our consolidated
earnings and profitability for the fiscal year ending March 31, 2021 (as compared to the prior fiscal year), with
the greater impact occurring in the first half of the fiscal year. We expect the impact will primarily be due to a
decrease in consolidated net business profit resulting from lower profit in our businesses and an increase in credit
costs, reflecting our expectation of further deterioration in the macroeconomic environment and an increase in
the provision for loan losses. We also expect an increase in risk-weighted assets which will have a small negative
impact on our capital ratios.
The outlook for the fiscal year ending March 31, 2021 set forth above is based on earnings forecasts that we
prepared under Japanese GAAP, which is the basis of accounting that we use for financial reporting purposes in
Japan. See "Presentation of Financial and Other Information." We do not publish forecasts of our results of
operations prepared on an IFRS basis, and it is uncertain whether our outlook for the fiscal year ending
March 31, 2021 would be substantially different if it had been based on earnings forecasts that we prepared under
IFRS. Historically, there have been significant differences in our reported results of operations under IFRS and
Japanese GAAP. For example, in the fiscal year ended March 31, 2020, there was a significant difference in the
calculation of the allowance for loan losses, which partially reflects a methodological difference in the way that
IFRS and Japanese GAAP incorporate information about the external environment, including the impact of the
COVID-19 pandemic on the economic outlook, in credit risk assessments. As a result, we recorded significantly
higher provisions for loan losses under IFRS than under Japanese GAAP for the fiscal year ended March 31,
2020. See "Item 5. Operating and Financial Review and Prospects--Overview--Critical Accounting Estimates
and Judgments--Allowance for Loan Losses" in our most recent annual report on Form 20-F. Accounting
differences such as this may continue to result in large variances in our reported financial results under IFRS and
Japanese GAAP. See "Item 5.A. Operating Results--Reconciliation with Japanese GAAP" in our most recent
annual report on Form 20-F for a summary of certain differences between IFRS and Japanese GAAP.
Our current expectations of the impact of the COVID-19 pandemic on our Japanese GAAP earnings outlook
for the fiscal year ending March 31, 2021 are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking statements are based on management's current
beliefs and expectations, speak only as of the date of this prospectus supplement, and are subject to significant
risks and uncertainties. Our Japanese GAAP earnings outlook was formulated based on specific estimates,
judgments and assumptions, including prospective assumptions about the operating environment,
macroeconomic conditions and the financial and operating conditions of our customers and counterparties. Due
to the significant risks and uncertainties associated with these estimates, judgments and assumptions, as well as
the continuously evolving nature of the COVID-19 crisis, from both a global public health and economic
standpoint in Japan and overseas, there can be no assurance that the actual impact of the COVID-19 pandemic
S-2

on our results will be in line with our current expectations. For example, if the deterioration in macroeconomic
conditions, particularly in sectors or geographies to which we have greater exposure, turns out to be more severe
than anticipated, we may be required to record higher credit costs than we currently anticipate. We do not
undertake to update any forward-looking statements.
See "Cautionary Statement Regarding Forward-Looking Statements" and "Item 3.D. Key Information--
Risk Factors" in our most recent annual report on Form 20-F for a further discussion of risks and uncertainties,
including risks specifically related to the impact of the COVID-19 pandemic on our business, results of
operations and financial condition, and other factors that could cause actual results to differ materially because
of those risks and uncertainties.
S-3

The Offering
The following is a brief summary of certain terms of this offering. Some of the terms and conditions
described below are subject to important limitations and exceptions. For a more complete description of the
terms of the notes, see "Description of the Notes."
Issuer . . . . . . . . . . . . . . . . . . . . . . . . . . . . Sumitomo Mitsui Financial Group, Inc.
Securities Offered . . . . . . . . . . . . . . . . . . $850,000,000 aggregate principal amount of 2.142% subordinated
notes due September 23, 2030.
The notes will be issued in fully registered form, without coupons, in
denominations of $2,000 in principal amount and integral multiples of
$1,000 in excess thereof.
Offering Price . . . . . . . . . . . . . . . . . . . . . 100%, plus accrued interest from September 23, 2020, if settlement
occurs after that date.
Maturity Date . . . . . . . . . . . . . . . . . . . . . The notes will mature on September 23, 2030, unless previously
redeemed or otherwise cancelled, and provided that a Non-Viability
Event has not occurred.
Ranking . . . . . . . . . . . . . . . . . . . . . . . . . . The notes will constitute our direct and unsecured obligations and
shall at all times rank pari passu and without any preference among
themselves and at least equally and ratably with all of our
indebtedness which is subordinated to Senior Indebtedness (as
defined herein) and is in priority to all of our perpetual subordinated
indebtedness, including indebtedness in respect of preference or other
shares or any other indebtedness which ranks, or is expressed to rank,
pari passu with, or junior to, indebtedness in respect of perpetual
subordinated indebtedness. See "Description of the Notes--Ranking"
and "Description of the Notes--Subordination."
Payment of Principal and Interest . . . . . . Interest on the notes will accrue at the rate of 2.142% per annum from
September 23, 2020.
We will pay 100% of the principal amount of the notes at the maturity
date, unless the notes are previously redeemed or otherwise cancelled.
We will pay interest on the notes semiannually in arrears on March 23
and September 23 of each year (each an "interest payment date"),
beginning on March 23, 2021, to the persons in whose names the
notes are registered as of the close of business on the fifteenth day
before the interest payment date (whether or not a business day).
Interest on the notes will be paid to but excluding the relevant interest
payment date.
S-4